BioSpace News Archive

BioCapital

Know Diabetes by Heart™ Awards $900,000 for Community Education

Ten grants from the American Diabetes Association and the American Heart Association’s joint initiative aim to decrease heart disease and stroke among people with type 2 diabetes

February 25, 2021

·

5 min read

FDA

FDA Approves Targeted Treatment for Rare Duchenne Muscular Dystrophy Mutation - Feb 25, 2021

The U.S. Food and Drug Administration granted approval for Amondys 45 injection for the treatment of Duchenne muscular dystrophy in patients who have a confirmed mutation of the DMD gene that is amenable to exon 45 skipping.

February 25, 2021

·

4 min read

Pharm Country

Pitt’s Plans for Growth of Regional Life Sciences Cluster Get Boost From $25 Million Gift; Advancements in Vision Care Lead the Way

Philadelphia has its pharmaceutical cluster, San Francisco is known for its tech startups, and Boston boasts about its investment capital.

February 25, 2021

·

4 min read

Business

Collegium Reports Record Full-Year 2020 Revenue of $310.0 Million

2020 First Full-Year of Profitability, Driven by Xtampza® ER Revenue Growth and the Nucynta® Acquisition

February 25, 2021

·

15 min read

Business

ICU Medical, Inc. Announces Fourth Quarter 2020 Results and Provides Fiscal Year 2021 Guidance

ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended December 31, 2020.

February 25, 2021

·

14 min read

Business

Sientra to Report Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021

Sientra, Inc., a medical aesthetics company uniquely focused on plastic surgeons, announced that it will release financial results for the fourth quarter and full year of 2020 after the close of trading on Thursday, March 11, 2021.

February 25, 2021

·

1 min read

Business

Natus Medical Announces Fourth Quarter 2020 Financial Results

Natus Medical Incorporated, a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced financial results for the three months and full year ended December 31, 2020.

February 25, 2021

·

20 min read

Business

GenMark Diagnostics Reports Fourth Quarter and Full Year 2020 Results

GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the fiscal year and quarter ended December 31, 2020.

February 25, 2021

·

13 min read

Business

Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results

Zogenix (NASDAQ: ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, today provided a corporate update and announced financial results for the fourth quarter and full-year ended December 31, 2020.

February 25, 2021

·

11 min read

Business

Cytokinetics Reports Fourth Quarter 2020 Financial Results

Cytokinetics, Incorporated reported financial results for the fourth quarter and full year 2020. Net loss for the fourth quarter was $43.9 million or $0.62 per share and the net loss for the year 2020 was $127.3 million or $1.97 per share.

February 25, 2021

·

17 min read